The new year is still young, but there is already lots happening and the National Breast Cancer Foundation team have hit the ground running.
The first exciting event of the year is the annual Mother’s Day Classic fun run or walk. It’s great for people of all ages and fitness levels. Being part of the atmosphere and feeling the community spirit is always a highlight for me.
Another key event in the calendar is announcing the grants that have been awarded for 2016. Thanks to generous support from people like you, this year the National Breast Cancer Foundation has committed around $12 million to fund more than 30 research projects that will contribute towards our goal of zero deaths from breast cancer by 2030. This year we have continued to fund innovative researchers who will explore promising areas of investigation. These projects include more effective immunotherapies for hard-to-treat breast cancers; targeted treatment delivery systems; and predictive tests for relapsing cancer.
The National Breast Cancer Foundation has also launched the Leadership Fellowship, a five year grant that allows a senior researcher to address some of the big questions in breast cancer. In our most recent issue of our Towards Zero newsletter, you can read about the inaugural recipient, Professor Nehmat Houssami, and how her research aims to gather evidence on the benefits of 3D mammography. Finally, I am thrilled to announce that we have appointed a new CEO: Dr Sarah Hosking. Dr. Hosking has most recently been CEO of the Melbourne-based charity Very Special Kids, and has held multiple CEO roles and board positions. I know she will be a fantastic asset to the team at the National Breast Cancer Foundation and will lead our organisation into an exciting new future.
Elaine Henry OAM, NBCF Chair